New Standards for CLL Care With BTK Inhibitors PeerView Oncology 1:36:53 3 years ago 406 Далее Скачать
Highlights from a CLL session: BTKis, personalizing care, novel regimens, & more VJHemOnc – Video Journal of Hematology & HemOnc 3:17 2 months ago 66 Далее Скачать
Treating high risk CLL with BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 1:41 3 years ago 193 Далее Скачать
Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL PeerView Oncology 1:02:27 3 years ago 206 Далее Скачать
Symposium | Customizing first-line BTK inhibitors for CLL: Unmet needs with BTK inhibitors Lymphoma Hub 4:38 3 weeks ago 53 Далее Скачать
Treating CLL after venetoclax or BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 1:42 2 years ago 737 Далее Скачать
Treating patients with CLL who progress after BTK inhibitor therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:22 3 years ago 419 Далее Скачать
Moving towards personalized therapy in CLL & sequencing BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 1:09 1 year ago 106 Далее Скачать
CLL Care With BTK Inhibitors: Selection, Safety, and Sequencing Across the Disease Continuum PeerView Oncology 1:13:17 4 years ago 110 Далее Скачать
Non-covalent vs covalent BTK inhibitors in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:23 2 years ago 794 Далее Скачать
Combining BTK and BCL-2 inhibitors for the treatment of CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:26 2 years ago 128 Далее Скачать
The current role of continuous BTK inhibitors in CLL treatment: benefits and drawbacks VJHemOnc – Video Journal of Hematology & HemOnc 3:35 1 year ago 333 Далее Скачать
BTK and BCL2 inhibitor resistance in CLL: session highlights VJHemOnc – Video Journal of Hematology & HemOnc 3:12 2 years ago 132 Далее Скачать
Updates for Pharmacists: Utilizing BTK Inhibitors for the Treatment of CLL Medscape 33:15 6 months ago 2 Далее Скачать
